FdaApplication
ANDA 216988
Identifiers
- fda_app_no: ANDA216988
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH LTD |
| application_type | ANDA |
| approval_date | 2026-05-21 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLONAZEPAM | CLONAZEPAM | 0.125MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLONAZEPAM | CLONAZEPAM | 1MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLONAZEPAM | CLONAZEPAM | 2MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLONAZEPAM | CLONAZEPAM | 0.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| CLONAZEPAM | CLONAZEPAM | 0.25MG | TABLET, ORALLY DISINTEGRATING;ORAL |
5 products